Menu Search
Equities

Prolight Diagnostics AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0G5I:LSE

Prolight Diagnostics AB (publ)

Actions
  • Price (SEK)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta2.4404
Data delayed at least 20 minutes, as of Nov 28 2024.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.

  • Revenue in SEK (TTM)0.00
  • Net income in SEK-35.57m
  • Incorporated1999
  • Employees21.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.